Clinical Trial Update: Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous fecal microbiota transplantation to prevent Clostridioides difficile infection in recipients of allogeneic hematopoietic ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Autologous fecal microbiota transplantation (autologous fecal microbiota transplantation)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Allogeneic Hematopoietic Stem Cell | Phase 2 | Status: ACTIVE_NOT_RECRUITING